
A new study has shed light on how a class of diabetes drugs may protect the kidneys — not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to the study published in The Journal of Clinical Investigation.

Biological markers may help predict which patients will benefit most from specific therapies to treat prostate cancer, according to a study published in the journal Cell.

Northwestern Medicine scientists have discovered that a subset of laboratory-modified T-cells can promote the repair of lung tissue damaged by viral pneumonia, according to a recent study published in The Journal of Clinical Investigation.

A novel monoclonal antibody treatment developed in collaboration with Northwestern Medicine scientists reduced inflammation and immune dysregulation in mouse models of sepsis, underscoring the antibody’s therapeutic potential in treating the disease, according to a recent study.

Northwestern scientists have created a new lifestyle medicine program that uses three wearable sensors to capture real-world eating behavior in unprecedented detail.

A new study has found that prompt administration of opioid pain relief in emergency departments reduces the likelihood of hospitalization for children with sickle cell disease, according to findings published in JAMA Pediatrics.

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study published in The Lancet Neurology.

Two chronic pain treatments based on cognitive behavioral therapy (CBT) — telehealth coaching and online self-completed pain coping skills training — improved pain severity and quality of life compared to usual care in patients with high-impact chronic pain, according to a recent study published in JAMA.

A cardiovascular disease risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients most benefit from statin therapy, according to a recent study published in JAMA Cardiology.

Scientists have discovered more than 100 new epigenetic biomarkers that may help predict cardiovascular disease risk and inform preventive care measures to improve long-term outcomes, according to a recent study published in Circulation.
Notifications